SYRE Market Cap History Table | ||||||
Also see: SYRE Shares Outstanding History and SYRE YTD Return |
SYRE Market Cap History Table | ||||||
Also see: SYRE Shares Outstanding History and SYRE YTD Return |
SYRE Market Cap History Chart | ||||||
+5032.90% CAGR Mouse over chart for data details
|
SYRE Stock Price Chart |
About Spyre Therapeutics Inc |
Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels. We show 2 historical shares outstanding datapoints in our SYRE shares outstanding history coverage, used to compute SYRE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SYRE market cap history over the course of time is important for investors interested in comparing SYRE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SYRE versus a peer is one thing; comparing SYRE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SYRE can fluctuate over the course of history. With this page we aim to empower investors researching SYRE by allowing them to research the SYRE market cap history. |
SYRE Current Stock Quote |
Free SYRE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
SYRE Share Performance |
Market Cap Peers |
Spyre Therapeutics (SYRE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SYRS Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.